Skip to Content

MedGen Inc MDIN

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

MDIN is trading at a 50% discount.
Price
$0.00
Fair Value
$8.14
Uncertainty
Extreme
1-Star Price
$1.93
5-Star Price
Economic Moat
Slny
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MDIN is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.00
Market Cap
$22.72
Volume/Avg
40,000 / 261,968

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

MedGen Inc is the United States based Med-Tech and Lifesciences company. It manufactures, sells and licenses healthcare products. The company operates in the business segments of Biomedical, Healthcare, Precision medicine and Pharmaceutical. Along with its subsidiaries, it provides medical device coating services, a platform enabling cell using hydrogel, direct-write printing devices and artificial human organs. It also offers smart bandages and eTextiles.
Sector
Healthcare
Industry
Pharmaceutical Retailers
Stock Style Box
Small Value
Total Number of Employees
3

Valuation

Metric
MDIN
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
MDIN
Quick Ratio
0.00
Current Ratio
0.00
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
MDIN
Return on Assets (Normalized)
−630,597.07%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Pharmaceutical Retailers Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
WBA
Walgreens Boots Alliance IncCtyrjbzWpdgw$15.2 Bil
RADLY
Raia Drogasil SA ADRJnmsjb$8.2 Bil
ALBBY
Alibaba Health Information Technology Ltd ADRXpwjzj$5.4 Bil
ALBHF
Alibaba Health Information Technology LtdBlmvsgc$5.4 Bil
CLCGY
Clicks Group Ltd ADRQbctbsk$3.5 Bil
TSUSF
Tsuruha Holdings IncWdbdzx$3.2 Bil
SGIPF
Sugi Holdings Co LtdZsldc$2.8 Bil
SAEYY
Redcare Pharmacy NV ADRZvss$2.6 Bil
SHPPF
Redcare Pharmacy NVBtpkd$2.6 Bil
ZRSEF
DocMorris AGFzpwctg$1.1 Bil

Sponsor Center